AAP
AURA icon

Arax Advisory Partners’s Aura Biosciences AURA Stock Holding History

Arax Advisory Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Buy
4,422
+3,400
+333% +$24.3K ﹤0.01% 3646
2026
Q1 		$6.84K Buy
1,022
+753
+280% +$4.32K ﹤0.01% 2647
2025
Q4 		$1.47K Sell
269
-151
-36% -$897 ﹤0.01% 3375
2025
Q3 		$2.6K Buy
420
+125
+42% +$817 ﹤0.01% 3049
2025
Q2 		$1.85K Buy
+295
New +$1.73K ﹤0.01% 2594
2025
Q1 		– Sell
-102
Closed -$839 – 2692
2024
Q4 		$839 Buy
102
+53
+108% +$499 ﹤0.01% 2208
2024
Q3 		$437 Hold
49
– – ﹤0.01% 2419
2024
Q2 		$371 Buy
+49
New +$359 ﹤0.01% 2372

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Arax Advisory Partners's AURA Position: Q2 2026 in Review

Arax Advisory Partners increased its Aura Biosciences (AURA) stake by 333% in Q2 2026, buying an estimated $24.3K and bringing the position to 4,422 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3646.

Arax Advisory Partners first reported a position in AURA in Q2 2024 and has held it in 8 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Arax Advisory Partners held 4,422 shares of Aura Biosciences worth $31.4K as of Q2 2026.
  • Arax Advisory Partners bought 3,400 Aura Biosciences shares in Q2 2026, an estimated $24.3K.
  • Aura Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3646 holding.
  • Arax Advisory Partners first reported a position in Aura Biosciences in Q2 2024 and has held it in 8 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.